BioSpace News Archive

The trial evaluated crenezumab’s ability to slow Alzheimer’s disease in cognitively unimpaired people with a specific gene mutation that causes early-onset Alzheimer’s disease.

According to reports citing “people familiar with the matter,” Kyowa Kirin, a specialty pharma company, could be lining up the sale of $1 billion worth of assets on the international market.

In a study conducted by researchers at Stanford University, three pediatric patients with a rare genetic disease that often results in kidney failure received kidney transplants.

The FDA approved Rhythm Pharmaceutical’s Imcivree (setmelanotide) for patients with Bardet-Biedl syndrome.

Exelixis, Inc. and BioInvent International AB announced that the companies have entered into an option and license agreement focused on the identification and development of novel antibodies for use in IO therapeutics.

Wilmington, Delaware, United States: According to Transparency Market Research’s latest report on the global digital pathology market for the historical period 2017–2018 and forecast period 2019–2027, rising awareness about digital pathology and increase in demand for advanced technology are the factors likely to boost the growth of digital pathology market.

Wilmington, Delaware, United States: Transparency Market Research delivers key insights on the global AI in medical imaging market.

Wilmington, Delaware, United States: The surgical lighting systems market is likely to witness promising growth across the forecast period of 2021-2031 owing to the rising incidences of lifestyle disorders across the globe.

Wilmington, Delaware, United States: Protein chip, actually a protein microarray strategy, has been a promising high-throughput approach utilized in disease rate monitoring, and clinical diagnostics.

The quest for turning the standard metal types into useful medical tubing is still a quite complicated process.